中国药物警戒 ›› 2010, Vol. 7 ›› Issue (4): 208-210.

• 循证药学 • 上一篇    下一篇

国际Cochrane协作网有关药品安全性评价的证据概括

夏芸1, 李昕雪1, 刘建平1,2*   

  1. 1北京中医药大学循证医学中心,北京 100029;
    2挪威国家补充与替代医学研究中心,挪威 9037
  • 收稿日期:2016-02-19 修回日期:2016-02-19 出版日期:2010-04-08 发布日期:2016-02-19
  • 通讯作者: 刘建平,男,研究生导师,循证中医药临床 研究。Email: jianping_liu@fagmed.uit.no
  • 作者简介:夏芸,女,在读博士研究生,循证医学在中医临床评价中的应用。

The Evidence Summary of Drug Safety Evaluation in the Cochrane Collaboration

XIA Yun1, LI Xin-xue1, LIU Jian-ping1,2,*   

  1. 1Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China;
    2National Research Center in Complementary and Alternative Medicine(NAFKAM), University of Tromso, Tromso 9037, Norway
  • Received:2016-02-19 Revised:2016-02-19 Online:2010-04-08 Published:2016-02-19

PDF (PC)

283

摘要： 目的 对当前可获得的Cochrane协作网有关药品安全性评价的证据进行概括。方法 电子检索Cochrane图书馆（光盘版）2009年第3期。检索词包括“药品不良反应”和“药品安全性”。结果 与结论 检索结果涉及Cochrane系统评价、非Cochrane系统评价、临床试验、方法学研究、技术评估和经济学评价六个方面的文章,药品安全性的评价主要与疗效评价同期进行,目前Cochrane协作网尚无专门评价药品安全性的系统评价。

关键词: Cochrane协作网, 药品安全性, 评价, 证据, 概括

Abstract: Objective To summarize the evidence related to drug safety available from the Cochrane Collaboration. Methods Electronic searching on the Cochrane Library(2009 Issue 3), the searching terms included adverse drug reaction and drug safety. Results ＆Condusion Articles related to 6 aspects including Cochrane systematic review, abstracts of non-Cochrane systematic review, clinical trials, methodological study, health technology assessment and economical evaluation, respectively, were reviewed. The safety was evaluated along with efficacy or effectiveness of drugs. Currently, there has been no specific systematic review focusing on drug safety in the Cochrane Collaboration.

Key words: The Cochrane Collaboration, drug safety, evaluation, evidence, summary

中图分类号: